HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epstein-Barr Virus (EBV)-induced B-cell Lymphoproliferative Disorder Mimicking the Recurrence of EBV-associated Hemophagocytic Lymphohistiocytosis.

Abstract
We describe the case of a 23-month-old male infant with Epstein-Barr virus (EBV)-associated lymphoproliferative disorder, which mimicked the recurrence of EBV-associated hemophagocytic lymphohistiocytosis. Chemotherapy with dexamethasone, etoposide, and cyclosporine resolved fever, hepatosplenomegaly, and pancytopenia. However, on day 81 of illness, the patient developed similar symptoms. Plasma EBV-DNA levels markedly increased again, but no T-cell clonality was observed. B cells were identified to be infected with EBV. He was successfully treated with rituximab, dexamethasone and etoposide. When recurrence of EBV-associated hemophagocytic lymphohistiocytosis is suspected, performing tests to identify the infected cells will enable accurate understanding of the clinical condition, resulting in proper treatments.
AuthorsYuki Yatsushiro, Takuro Nishikawa, Aki Saito, Yozo Nakazawa, Ken-Ichi Imadome, Shunsuke Nakagawa, Yuichi Kodama, Yasuhiro Okamoto, Hirokazu Kanegane, Yoshifumi Kawano
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 41 Issue 1 Pg. e44-e46 (01 2019) ISSN: 1536-3678 [Electronic] United States
PMID29324572 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Viral
  • Rituximab
  • Etoposide
  • Dexamethasone
Topics
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
  • B-Lymphocytes (metabolism, virology)
  • DNA, Viral (blood)
  • Dexamethasone (administration & dosage)
  • Epstein-Barr Virus Infections (blood, diagnosis, drug therapy)
  • Etoposide (administration & dosage)
  • Herpesvirus 4, Human
  • Humans
  • Infant
  • Lymphohistiocytosis, Hemophagocytic (blood, diagnosis, drug therapy, virology)
  • Lymphoproliferative Disorders (blood, diagnosis, drug therapy, virology)
  • Male
  • Rituximab (administration & dosage)
  • T-Lymphocytes (metabolism, virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: